These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8814058)

  • 41. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus.
    Neuwelt CM; Lacks S; Kaye BR; Ellman JB; Borenstein DG
    Am J Med; 1995 Jan; 98(1):32-41. PubMed ID: 7825616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.
    Petri M; Brodsky RA; Jones RJ; Gladstone D; Fillius M; Magder LS
    Arthritis Rheum; 2010 May; 62(5):1487-93. PubMed ID: 20131296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Aggressive therapy of highly active systemic lupus erythematosus].
    Graninger W
    Acta Med Austriaca; 1996; 23(4):129-33. PubMed ID: 9036724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
    Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide.
    Ciruelo E; de la Cruz J; López I; Gómez-Reino JJ
    Arthritis Rheum; 1996 Dec; 39(12):2028-34. PubMed ID: 8961908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclophosphamide boluses induce micronuclei expression in buccal mucosa cells of patients with systemic lupus erythematosus independent of cytochrome P450 2D6 status.
    Aceves Avila FJ; Esquivel Nava GA; Gallegos Arreola MP; Gómez Meda B; Zúñiga González G; Ramos-Remus C
    J Rheumatol; 2004 Jul; 31(7):1335-9. PubMed ID: 15229952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications.
    Badsha H; Kong KO; Lian TY; Chan SP; Edwards CJ; Chng HH
    Lupus; 2002; 11(8):508-13. PubMed ID: 12220105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.
    Munyangango EM; Le Roux-Villet C; Doan S; Pascal F; Soued I; Alexandre M; Heller M; Lièvre N; Aucouturier F; Caux F; Laroche L; Prost-Squarcioni C
    Br J Dermatol; 2013 Feb; 168(2):381-90. PubMed ID: 22963186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy.
    Lim CC; Tung YT; Tan BH; Lee PH; Mok I; Oon L; Chan KP; Choo JC
    Nephrology (Carlton); 2018 Jul; 23(7):676-681. PubMed ID: 28480520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
    Kan H; Nagar S; Patel J; Wallace DJ; Molta C; Chang DJ
    Clin Ther; 2016 Mar; 38(3):610-24. PubMed ID: 26907503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytochrome P450 polymorphism as a predictor of ovarian toxicity to pulse cyclophosphamide in systemic lupus erythematosus.
    Singh G; Saxena N; Aggarwal A; Misra R
    J Rheumatol; 2007 Apr; 34(4):731-3. PubMed ID: 17407229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian failure and flares of systemic lupus erythematosus.
    Mok CC; Wong RW; Lau CS
    Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
    Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
    J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
    Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS
    Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
    Somers EC; Marder W; Christman GM; Ognenovski V; McCune WJ
    Arthritis Rheum; 2005 Sep; 52(9):2761-7. PubMed ID: 16142702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus.
    Kabadi S; Yeaw J; Bacani AK; Tafesse E; Bos K; Karkare S; DeKoven M; Vina ER
    Lupus; 2018 Oct; 27(11):1799-1809. PubMed ID: 30068254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic lupus erythematosus and infections: a retrospective study in Saudis.
    Al-Rayes H; Al-Swailem R; Arfin M; Sobki S; Rizvi S; Tariq M
    Lupus; 2007; 16(9):755-63. PubMed ID: 17728372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
    Marks SD; Patey S; Brogan PA; Hasson N; Pilkington C; Woo P; Tullus K
    Arthritis Rheum; 2005 Oct; 52(10):3168-74. PubMed ID: 16200620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
    Lavalle-Graef A; Villegas-Acosta L; Lavalle C
    Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
    Mok CC; Chan PT; To CH
    Arthritis Rheum; 2013 Jan; 65(1):206-10. PubMed ID: 23044647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.